Low-dose naltrexone: A unique treatment for amyopathic dermatomyositis

5Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Gottron papules, a heliotrope rash, scalp and extremity erythema, pruritus, and fatigue are the characteristic signs and symptoms of amyopathic dermatomyositis (ADM). Amyopathic dermatomyositis is considered a distinct entity from dermatomyositis (DM) because the characteristic muscle weakness and muscle enzyme elevations of DM are absent in ADM. With respects to treatment, ADM treatments have traditionally included topical corticosteroids and/or systemic immunosuppressants and immunemodulators. Herein we present a patient with refractory ADM that was responsive to low-dose naltrexone therapy.

Cite

CITATION STYLE

APA

Manudhane, A. P., Schrom, K. P., Ezaldein, H. H., & Armile, J. A. (2019). Low-dose naltrexone: A unique treatment for amyopathic dermatomyositis. Dermatology Online Journal, 25(6). https://doi.org/10.5070/d3256044451

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free